Quantcast

Latest acetylcysteine Stories

2014-09-18 12:24:00

DUBLIN, Sept. 18, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global N-acetylcysteine Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global N-acetylcysteine Industry Report 2014 is a professional and in-depth study on the current state of the global N-acetylcysteine industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain...

2014-07-22 16:27:13

NASHVILLE, Tenn., July 22, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release second quarter 2014 financial results after the market closes on Tuesday, August 5, 2014. A conference call and live Internet webcast will be held on Tuesday, August 5, 2014, at 4:30 p.m. Eastern Time to discuss the results. http://photos.prnewswire.com/prnvar/20140505/84325 To participate in the call, please dial 877-303-1298 (for U.S. callers) or...

2014-05-30 23:07:00

Increase glutathione levels and improve the body’s ability to produce glutathione. New York, NY (PRWEB) May 30, 2014 Clinical Strength Glutathione Plus contains 5 ingredients specifically chosen to increase glutathione levels and improve the body’s ability to produce glutathione. Glutathione is the master antioxidant of the body, essential for good health. Health Benefits:     Increases glutathione levels     Promotes production of...

2014-05-18 16:20:49

Results from Boehringer Ingelheim, InterMune and IPFnet clinical trials discussed CHICAGO, May 18, 2014 /PRNewswire-USNewswire/ -- WHO: The Pulmonary Fibrosis Foundation (PFF) will discuss results from recent idiopathic pulmonary fibrosis (IPF) clinical trials in an upcoming webinar. Boehringer Ingelheim and InterMune both recently released data from their Phase III randomized, placebo-controlled trials, each demonstrating efficacy for those living with IPF. Also results from the...

2014-05-07 08:31:48

-Vaprisol marks new product for hospital sales force NASHVILLE, Tenn., May 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced the launch of its active promotional campaign to support its new Vaprisol(®) product. Cumberland will promote Vaprisol across the United States through its hospital sales force. A National Sales Meeting was convened this week to officially launch active promotion and other efforts to support the brand. Cumberland acquired...

2014-04-29 16:32:16

NASHVILLE, Tenn., April 29, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2014 financial results after the market closes on Tuesday, May 13, 2014. A conference call and live Internet webcast will be held on Tuesday, May 13, 2014, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of...

2014-03-07 16:22:47

NASHVILLE, Tenn., March 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the efficacy and safety of Caldolor(®) (ibuprofen) Injection will be presented at the Pediatric Anesthesiology 2014 conference in Fort Lauderdale, Florida. The pediatric study met its primary endpoint demonstrating that Caldolor was associated with a statistically significant reduction in temperature within the first 2 hours of...

2014-03-03 08:31:51

NASHVILLE, Tenn., March 3, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol(®) from Astellas Pharma US, Inc. Vaprisol(®) is a patented, prescription brand indicated to raise serum sodium levels in hospitalized patients with hyponatremia. The product was developed and registered by Astellas and was commercially launched in 2006. It is one of two branded prescription products indicated for the treatment of hyponatremia....

2014-02-27 16:27:17

NASHVILLE, Tenn., Feb. 27, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release 2013 year-end financial results after the market closes on Tuesday, March 4, 2014. A conference call and live Internet webcast will be held on Tuesday, March 4, 2014, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the...

2014-02-14 16:25:50

BEDFORD, Ohio, Feb. 14, 2014 /PRNewswire/ -- Ben Venue Laboratories, Inc. today issued a nationwide voluntary product recall: Acetylcysteine Solution 10%, USP, (Manufactured for Roxane Laboratories, Inc.) 10%, 30 mL per vial - NDC #0054-3025-02 - Lot 2005479 - Exp. Date March 2014 This voluntary recall was initiated on February 14, 2014 after the discovery of a single visible glass particle in a vial within the lot listed above. There have been no complaints or adverse events related to a...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related